NEWS
All News
FDA Briefs
Oncology Icons
Special Reports
Voices from the Field
CONFERENCES
Conference Coverage
Conference Listing
Data Dialogue with the Oncology Brothers
MEDIA
All Videos
Case-Based Peer Perspectives
Expert Perspective Virtual Tumor Board
Interviews
Investigator Perspectives
Medical World News
Pivotal Practice Views with the Oncology Brothers
Podcasts
Precision Medicine
Speaking Out
PUBLICATIONS
All Publications
Evolving Paradigms
Peers & Perspectives in Oncology
Targeted Therapies in Oncology
CASE-BASED ROUNDTABLE
PARTNERS
RESOURCES
CME/CE
Clinical Trials
Precision Medicine Perspectives
Press Releases
Sponsored Content
Treatment Resources
SUBSCRIBE
Choose Specialty
BRAIN CANCER
BREAST CANCER
BREAST CANCER
GENITOURINARY CANCERS
GENITOURINARY CANCERS
GENITOURINARY CANCERS
GENITOURINARY CANCERS
GENOMIC TESTING
GENOMIC TESTING
GI CANCERS
GI CANCERS
GI CANCERS
GI CANCERS
GI CANCERS
GYNECOLOGIC CANCERS
GYNECOLOGIC CANCERS
GYNECOLOGIC CANCERS
GYNECOLOGIC CANCERS
HEAD & NECK CANCERS
HEMATOLOGY
HEMATOLOGY
IMMUNOTHERAPY
IMMUNOTHERAPY
LEUKEMIAS
LEUKEMIAS
LEUKEMIAS
LEUKEMIAS
LUNG CANCER
LUNG CANCER
LUNG CANCER
LUNG CANCER
LUNG CANCER
LYMPHOMAS
LYMPHOMAS
LYMPHOMAS
LYMPHOMAS
MPNs
MULTIPLE MYELOMA
NTRK GENE FUSIONS
SARCOMA
SKIN CANCERS
SKIN CANCERS
THYROID CANCERS
Spotlight -
Biomarker-Driven Lung Cancer
GIST
HER2 Breast Cancer
Chronic Lymphocytic Leukemia
Small Cell Lung Cancer
Renal Cell Carcinoma
Choose Specialty
BRAIN CANCER
BREAST CANCER
BREAST CANCER
GENITOURINARY CANCERS
GENITOURINARY CANCERS
GENITOURINARY CANCERS
GENITOURINARY CANCERS
GENOMIC TESTING
GENOMIC TESTING
GI CANCERS
GI CANCERS
GI CANCERS
GI CANCERS
GI CANCERS
GYNECOLOGIC CANCERS
GYNECOLOGIC CANCERS
GYNECOLOGIC CANCERS
GYNECOLOGIC CANCERS
HEAD & NECK CANCERS
HEMATOLOGY
HEMATOLOGY
IMMUNOTHERAPY
IMMUNOTHERAPY
LEUKEMIAS
LEUKEMIAS
LEUKEMIAS
LEUKEMIAS
LUNG CANCER
LUNG CANCER
LUNG CANCER
LUNG CANCER
LUNG CANCER
LYMPHOMAS
LYMPHOMAS
LYMPHOMAS
LYMPHOMAS
MPNs
MULTIPLE MYELOMA
NTRK GENE FUSIONS
SARCOMA
SKIN CANCERS
SKIN CANCERS
THYROID CANCERS
Spotlight
NEWS
CONFERENCES
MEDIA
PUBLICATIONS
CASE-BASED ROUNDTABLE
PARTNERS
RESOURCES
SUBSCRIBE
Advertisement
Recent Advances in the Management of Myelofibrosis
: Episode 4
Case Presentation: A 73-Year-Old Man with Myelofibrosis (MF)
December 21, 2023
By
Aaron T. Gerds, MD, MS
Opinion
Video
Aaron Gerds, MD, MS, presents the case of a 73-year-old man with myelofibrosis.
EP: 1.
Available Treatment Options for Patients With Higher-Risk Myelofibrosis
EP: 2.
Current Unmet Needs in the Treatment of Myelofibrosis
EP: 3.
Emerging Treatments for Patients With Myelofibrosis
Now Viewing
EP: 4.
Case Presentation: A 73-Year-Old Man with Myelofibrosis (MF)
EP: 5.
Risk Stratification of Patients With MF
EP: 6.
Current Treatment Landscape for Patients With MF
EP: 7.
Momelotinib in Patients With MF
EP: 8.
Monitoring Patients on Treatment for MF
EP: 9.
Approaches to Switching Therapies for Patients With MF
EP: 10.
Factors for Consideration When Selecting a JAK Inhibitor for Patients With MF
EP: 11.
Safety of Available JAK Inhibitors for Treatment of MF
EP: 12.
Future of Myelofibrosis Treatments
Recent Videos
Related Content
Related Content